--- title: Newsroom | Life Science Newswire (6) description: (6) --- [![Life Science Newswire 2](https://news.lifesciencenewswire.com/hs-fs/hubfs/Life%20Science%20Newswire%202.png?width=203&height=60&name=Life%20Science%20Newswire%202.png "Life Science Newswire 2")](https://lifesciencenewswire.com/) - [Newsroom](https://news.lifesciencenewswire.com/newsroom) - [Back to the main site](https://lifesciencenewswire.com/) ![LSNewswire-main-header-banner-v2-1](https://news.lifesciencenewswire.com/hubfs/LSNewswire-main-header-banner-v2-1.jpg "LSNewswire-main-header-banner-v2-1") # Newsroom #### Categories ![Arrow](https://cdn2.hubspot.net/hubfs/3842749/ps4-Pack/sidebar.svg "Arrow") #### Subscribe![](https://cdn2.hubspot.net/hubfs/3842749/ps4-Pack/subscribe-rss-button.svg) ![](https://cdn2.hubspot.net/hubfs/3842749/ps4-Pack/close-button.svg) ### Choose a Category - [Agriculture (1)](https://news.lifesciencenewswire.com/newsroom/tag/agriculture) - [AI (2)](https://news.lifesciencenewswire.com/newsroom/tag/ai) - [Analytical Chemistry (42)](https://news.lifesciencenewswire.com/newsroom/tag/analytical-chemistry) - [Biomanufacturing (35)](https://news.lifesciencenewswire.com/newsroom/tag/biomanufacturing) - [biopharma (23)](https://news.lifesciencenewswire.com/newsroom/tag/biopharma) - [Bioprocessing (16)](https://news.lifesciencenewswire.com/newsroom/tag/bioprocessing) - [Biotechnology (252)](https://news.lifesciencenewswire.com/newsroom/tag/biotechnology) - [Cell Culture (10)](https://news.lifesciencenewswire.com/newsroom/tag/cell-culture) - [Clinical Diagnostics (38)](https://news.lifesciencenewswire.com/newsroom/tag/clinical-diagnostics) - [clinical research (6)](https://news.lifesciencenewswire.com/newsroom/tag/clinical-research) - [Clinical Research & Trials (117)](https://news.lifesciencenewswire.com/newsroom/tag/clinical-research-trials) - [Computing & Technology (62)](https://news.lifesciencenewswire.com/newsroom/tag/computing-it) - [Corporate, Finance & Investor (288)](https://news.lifesciencenewswire.com/newsroom/tag/corporate-finance-investor) - [COVID-19 (86)](https://news.lifesciencenewswire.com/newsroom/tag/covid-19) - [Diagnostics & Hospital Laboratory (38)](https://news.lifesciencenewswire.com/newsroom/tag/diagnostics-hospital-laboratory) - [Digital Pathology (2)](https://news.lifesciencenewswire.com/newsroom/tag/digital-pathology) - [Drug Discovery & Development (153)](https://news.lifesciencenewswire.com/newsroom/tag/drug-discovery-development) - [Energy & Environment (15)](https://news.lifesciencenewswire.com/newsroom/tag/energy-environment) - [excipients (1)](https://news.lifesciencenewswire.com/newsroom/tag/excipients) - [Food & Beverage (8)](https://news.lifesciencenewswire.com/newsroom/tag/food-beverage) - [General Chemistry (7)](https://news.lifesciencenewswire.com/newsroom/tag/general-chemistry) - [General Laboratory (58)](https://news.lifesciencenewswire.com/newsroom/tag/general-laboratory) - [General Science (5)](https://news.lifesciencenewswire.com/newsroom/tag/general-science) - [Healthcare (136)](https://news.lifesciencenewswire.com/newsroom/tag/healthcare) - [Hospital Management (7)](https://news.lifesciencenewswire.com/newsroom/tag/hospital-management) - [Life Science (26)](https://news.lifesciencenewswire.com/newsroom/tag/life-science) - [Manufacturing (2)](https://news.lifesciencenewswire.com/newsroom/tag/manufacturing) - [Materials Science (2)](https://news.lifesciencenewswire.com/newsroom/tag/materials-science) - [Medical Devices & Technology (26)](https://news.lifesciencenewswire.com/newsroom/tag/medical-devices-technology) - [Microbiology & Infection Control (18)](https://news.lifesciencenewswire.com/newsroom/tag/microbiology-infection-control) - [Microscopy & Imaging (47)](https://news.lifesciencenewswire.com/newsroom/tag/microscopy-imaging) - [Nanotech (2)](https://news.lifesciencenewswire.com/newsroom/tag/nanotech) - [Omics & Genetics (87)](https://news.lifesciencenewswire.com/newsroom/tag/omics-genetics) - [Pathology (5)](https://news.lifesciencenewswire.com/newsroom/tag/pathology) - [Pharma (118)](https://news.lifesciencenewswire.com/newsroom/tag/pharma) - [Pharmacy (5)](https://news.lifesciencenewswire.com/newsroom/tag/pharmacy) - [Research (47)](https://news.lifesciencenewswire.com/newsroom/tag/research) - [Veterinary (6)](https://news.lifesciencenewswire.com/newsroom/tag/veterinary) - [Water (8)](https://news.lifesciencenewswire.com/newsroom/tag/water) See all ### Subscribe to Email Updates ## Life Science Newswire ### Recent Posts Categories: [Biotechnology](https://news.lifesciencenewswire.com/newsroom/tag/biotechnology), [Computing & Technology](https://news.lifesciencenewswire.com/newsroom/tag/computing-it), [Drug Discovery & Development](https://news.lifesciencenewswire.com/newsroom/tag/drug-discovery-development), [Analytical Chemistry](https://news.lifesciencenewswire.com/newsroom/tag/analytical-chemistry), [Pharma](https://news.lifesciencenewswire.com/newsroom/tag/pharma) #### [Arctoris Launches Biophysics Centre of Excellence to Bridge the AI-Experimentation Gap in Drug Discovery](https://news.lifesciencenewswire.com/newsroom/arctoris-launches-biophysics-centre-of-excellence-to-bridge-the-ai-experimentation-gap-in-drug-discovery) March 16, 2026 ##### [READ MORE](https://news.lifesciencenewswire.com/newsroom/arctoris-launches-biophysics-centre-of-excellence-to-bridge-the-ai-experimentation-gap-in-drug-discovery) 0 Comments [Click here to read/write comments](https://news.lifesciencenewswire.com/newsroom/arctoris-launches-biophysics-centre-of-excellence-to-bridge-the-ai-experimentation-gap-in-drug-discovery#comments-listing) by [Life Science Newswire](https://news.lifesciencenewswire.com/newsroom/author/newswire) on Mar 16, 2026, 11:45:00 AM - [Tweet](https://twitter.com/share) Categories: [Omics & Genetics](https://news.lifesciencenewswire.com/newsroom/tag/omics-genetics), [Biotechnology](https://news.lifesciencenewswire.com/newsroom/tag/biotechnology), [Corporate, Finance & Investor](https://news.lifesciencenewswire.com/newsroom/tag/corporate-finance-investor) #### [University of Colorado grants license to Cirena for RNA-synthesis technology](https://news.lifesciencenewswire.com/newsroom/university-of-colorado-grants-license-to-cirena-for-rna-synthesis-technology) March 10, 2026 ##### [READ MORE](https://news.lifesciencenewswire.com/newsroom/university-of-colorado-grants-license-to-cirena-for-rna-synthesis-technology) 0 Comments [Click here to read/write comments](https://news.lifesciencenewswire.com/newsroom/university-of-colorado-grants-license-to-cirena-for-rna-synthesis-technology#comments-listing) by [Life Science Newswire](https://news.lifesciencenewswire.com/newsroom/author/newswire) on Mar 10, 2026, 11:59:59 AM - [Tweet](https://twitter.com/share) Categories: [Omics & Genetics](https://news.lifesciencenewswire.com/newsroom/tag/omics-genetics), [Biotechnology](https://news.lifesciencenewswire.com/newsroom/tag/biotechnology) #### [Epigenica AB launches EpiFinder™ cNUC: The first platform to simultaneously profile multiple histone marks and DNA methylation directly from circulating nucleosomes in plasma and serum](https://news.lifesciencenewswire.com/newsroom/epigenica-ab-launches-epifinder-cnuc-the-first-platform-to-simultaneously-profile-multiple-histone-marks-and-dna-methylation-directly-from-circulating-1771597224314b) February 25, 2026 ##### [READ MORE](https://news.lifesciencenewswire.com/newsroom/epigenica-ab-launches-epifinder-cnuc-the-first-platform-to-simultaneously-profile-multiple-histone-marks-and-dna-methylation-directly-from-circulating-1771597224314b) 0 Comments [Click here to read/write comments](https://news.lifesciencenewswire.com/newsroom/epigenica-ab-launches-epifinder-cnuc-the-first-platform-to-simultaneously-profile-multiple-histone-marks-and-dna-methylation-directly-from-circulating-1771597224314b#comments-listing) by [Life Science Newswire](https://news.lifesciencenewswire.com/newsroom/author/newswire) on Feb 25, 2026, 12:30:00 PM - [Tweet](https://twitter.com/share) Categories: [Pharma](https://news.lifesciencenewswire.com/newsroom/tag/pharma), [Clinical Research & Trials](https://news.lifesciencenewswire.com/newsroom/tag/clinical-research-trials), [Corporate, Finance & Investor](https://news.lifesciencenewswire.com/newsroom/tag/corporate-finance-investor) #### [Inceptua Group appoints healthcare industry leader Kurt Hilzinger as chairman of the board](https://news.lifesciencenewswire.com/newsroom/inceptua-group-appoints-healthcare-industry-leader-kurt-hilzinger-as-chairman-of-the-board) February 23, 2026 ##### [READ MORE](https://news.lifesciencenewswire.com/newsroom/inceptua-group-appoints-healthcare-industry-leader-kurt-hilzinger-as-chairman-of-the-board) 0 Comments [Click here to read/write comments](https://news.lifesciencenewswire.com/newsroom/inceptua-group-appoints-healthcare-industry-leader-kurt-hilzinger-as-chairman-of-the-board#comments-listing) by [Life Science Newswire](https://news.lifesciencenewswire.com/newsroom/author/newswire) on Feb 23, 2026, 1:30:00 PM - [Tweet](https://twitter.com/share) Categories: [Omics & Genetics](https://news.lifesciencenewswire.com/newsroom/tag/omics-genetics), [Clinical Research & Trials](https://news.lifesciencenewswire.com/newsroom/tag/clinical-research-trials), [Corporate, Finance & Investor](https://news.lifesciencenewswire.com/newsroom/tag/corporate-finance-investor) #### [Cirena launches high-purity long RNA to accelerate CRISPR and genome-editing research](https://news.lifesciencenewswire.com/newsroom/cirena-launches-high-purity-long-rna-to-accelerate-crispr-and-genome-editing-research) February 3, 2026 ##### [READ MORE](https://news.lifesciencenewswire.com/newsroom/cirena-launches-high-purity-long-rna-to-accelerate-crispr-and-genome-editing-research) 0 Comments [Click here to read/write comments](https://news.lifesciencenewswire.com/newsroom/cirena-launches-high-purity-long-rna-to-accelerate-crispr-and-genome-editing-research#comments-listing) by [Life Science Newswire](https://news.lifesciencenewswire.com/newsroom/author/newswire) on Feb 3, 2026, 11:59:59 AM - [Tweet](https://twitter.com/share) Categories: [Microscopy & Imaging](https://news.lifesciencenewswire.com/newsroom/tag/microscopy-imaging), [Clinical Research & Trials](https://news.lifesciencenewswire.com/newsroom/tag/clinical-research-trials), [Corporate, Finance & Investor](https://news.lifesciencenewswire.com/newsroom/tag/corporate-finance-investor) #### [Fidēs Imaging launches next-generation imaging core lab](https://news.lifesciencenewswire.com/newsroom/fidēs-imaging-launches-next-generation-imaging-core-lab) January 29, 2026 ##### [READ MORE](https://news.lifesciencenewswire.com/newsroom/fidēs-imaging-launches-next-generation-imaging-core-lab) 0 Comments [Click here to read/write comments](https://news.lifesciencenewswire.com/newsroom/fidēs-imaging-launches-next-generation-imaging-core-lab#comments-listing) by [Life Science Newswire](https://news.lifesciencenewswire.com/newsroom/author/newswire) on Jan 29, 2026, 12:00:01 PM - [Tweet](https://twitter.com/share) Categories: [Bioprocessing](https://news.lifesciencenewswire.com/newsroom/tag/bioprocessing), [Omics & Genetics](https://news.lifesciencenewswire.com/newsroom/tag/omics-genetics), [Research](https://news.lifesciencenewswire.com/newsroom/tag/research) #### [Epigenica launches EpiFinder™ Analysis Service, a fully managed platform for fast and reliable epigenomic insights](https://news.lifesciencenewswire.com/newsroom/epigenica-launches-epifinder-analysis-service-a-fully-managed-platform-for-fast-and-reliable-epigenomic-insights) January 27, 2026 ##### [READ MORE](https://news.lifesciencenewswire.com/newsroom/epigenica-launches-epifinder-analysis-service-a-fully-managed-platform-for-fast-and-reliable-epigenomic-insights) 0 Comments [Click here to read/write comments](https://news.lifesciencenewswire.com/newsroom/epigenica-launches-epifinder-analysis-service-a-fully-managed-platform-for-fast-and-reliable-epigenomic-insights#comments-listing) by [Life Science Newswire](https://news.lifesciencenewswire.com/newsroom/author/newswire) on Jan 27, 2026, 12:00:01 PM - [Tweet](https://twitter.com/share) Categories: [Healthcare](https://news.lifesciencenewswire.com/newsroom/tag/healthcare), [Medical Devices & Technology](https://news.lifesciencenewswire.com/newsroom/tag/medical-devices-technology) #### [Ceryx Medical (Ceryx) appoints leading MedTech executive Mark Strong as Non-Executive Director](https://news.lifesciencenewswire.com/newsroom/ceryx-medical-ceryx-appoints-leading-medtech-executive-mark-strong-as-non-executive-director) January 26, 2026 ##### [READ MORE](https://news.lifesciencenewswire.com/newsroom/ceryx-medical-ceryx-appoints-leading-medtech-executive-mark-strong-as-non-executive-director) 0 Comments [Click here to read/write comments](https://news.lifesciencenewswire.com/newsroom/ceryx-medical-ceryx-appoints-leading-medtech-executive-mark-strong-as-non-executive-director#comments-listing) by [Life Science Newswire](https://news.lifesciencenewswire.com/newsroom/author/newswire) on Jan 26, 2026, 12:00:00 PM - [Tweet](https://twitter.com/share) Categories: [Drug Discovery & Development](https://news.lifesciencenewswire.com/newsroom/tag/drug-discovery-development), [Clinical Research & Trials](https://news.lifesciencenewswire.com/newsroom/tag/clinical-research-trials) #### [Cycle Pharmaceuticals and Inceptua Group expand the Free Goods Programme for patients with Hereditary Tyrosinemia Type 1 (HT-1) and Alkaptonuria (AKU) to include Morocco and Egypt.](https://news.lifesciencenewswire.com/newsroom/cycle-pharmaceuticals-and-inceptua-group-expand-the-free-goods-programme-for-patients-with-hereditary-tyrosinemia-type-1-ht-1-and-alkaptonuria-aku-to-in-1767868706302) January 9, 2026 ##### [READ MORE](https://news.lifesciencenewswire.com/newsroom/cycle-pharmaceuticals-and-inceptua-group-expand-the-free-goods-programme-for-patients-with-hereditary-tyrosinemia-type-1-ht-1-and-alkaptonuria-aku-to-in-1767868706302) 0 Comments [Click here to read/write comments](https://news.lifesciencenewswire.com/newsroom/cycle-pharmaceuticals-and-inceptua-group-expand-the-free-goods-programme-for-patients-with-hereditary-tyrosinemia-type-1-ht-1-and-alkaptonuria-aku-to-in-1767868706302#comments-listing) by [Life Science Newswire](https://news.lifesciencenewswire.com/newsroom/author/newswire) on Jan 9, 2026, 11:00:00 AM - [Tweet](https://twitter.com/share) [Previous](https://news.lifesciencenewswire.com/newsroom/author/newswire/page/5) [All posts](https://news.lifesciencenewswire.com/newsroom/all) [Next](https://news.lifesciencenewswire.com/newsroom/author/newswire/page/7) ##### Browse more news ## Recent releases #### [Ceryx Medical manufactures first implantable heart failure device at King’s College London’s MAISI f...](https://news.lifesciencenewswire.com/newsroom/ceryx-medical-manufactures-first-implantable-heart-failure-device-at-kings-college-londons-maisi-facility) October 22, 2026 A first for both organisations: the first implantable device built by the UK’s national active implant manufacturing facility is Ceryx’s bioelectronic... ##### [READ MORE](https://news.lifesciencenewswire.com/newsroom/ceryx-medical-manufactures-first-implantable-heart-failure-device-at-kings-college-londons-maisi-facility) #### [Scope’s CRISPR Molecular Diagnostics CE Marked for Antifungal Resistance](https://news.lifesciencenewswire.com/newsroom/scopes-crispr-molecular-diagnostics-ce-marked-for-antifungal-resistance) October 6, 2026 Developed with AmplexDiagnostics, eazySNP brings scopeDx® into human diagnostics Scope Biosciences B.V., a Wageningen University spinoff life sciences... ##### [READ MORE](https://news.lifesciencenewswire.com/newsroom/scopes-crispr-molecular-diagnostics-ce-marked-for-antifungal-resistance) #### [CellCarta Establishes Strategic Partnership with Waters to Advance Companion Diagnostics Development](https://news.lifesciencenewswire.com/newsroom/cellcarta-establishes-strategic-partnership-with-waters-to-advance-companion-diagnostics-development) October 5, 2026 Collaboration combines CellCarta’s global clinical trial testing capabilities with Waters’ standardized flow cytometry platforms and expertise CellCar... ##### [READ MORE](https://news.lifesciencenewswire.com/newsroom/cellcarta-establishes-strategic-partnership-with-waters-to-advance-companion-diagnostics-development) ![LS-Newswire-reverse](https://news.lifesciencenewswire.com/hs-fs/hubfs/raw_assets/public/LifeScienceNewswire_June2020/images/LS-Newswire-reverse.png?width=150&name=LS-Newswire-reverse.png "LS-Newswire-reverse") Life Science Newswire is a division of BioStrata Ltd, with company registered address: 3rd Floor, 1 Ashley Road, Altrincham, Cheshire, England, WA14 2DT. Company registration number: 8233225  #### Useful information - [Cookie and privacy policy](https://lifesciencenewswire.com/cookie-privacy-policy/) - [Website terms and conditions](https://lifesciencenewswire.com/terms-and-conditions) - [Promotion terms and conditions](https://lifesciencenewswire.com/promotion_terms/)